The place for glycemic control in the surgical patient

Surgical Infections

Volumn 12, Issue 5, 2011, Pages 405-418

  May, Addison K ^a   Kauffmann, Rondi M ^a   Collier, Bryan R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL PATIENT; SYSTEMATIC REVIEW;

DIABETES MELLITUS; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; INTENSIVE CARE; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80155196015     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.019     Document Type: Review

References (125)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
2. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373:1798-1807.
3. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000;128:757-760.
4. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: A marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2:69-78.
5. Thorell A, Nygren J, Hirshman MF, et al. Surgery-induced insulin resistance in human patients: Relation to glucose transport and utilization. Am J Physiol 1999;276:E754-E761.
6. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
7. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intensive Care Med 2009;35:1738-1748.
8. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-3197.
9. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.
10. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
11. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care 2009;32:1119-1131.
12. Saberi F, Heyland D, Lam M, et al. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: An observational study. JPEN J Parenter Enteral Nutr 2008;32:227-235.
13. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982.
14. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001;22:607-612.
15. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360.
16. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252.
17. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004;56:1058-1062.
18. Mowery NT, Gunter OL, Dossett LA, et al. Failure to achieve euglycemia despite aggressive insulin control signals abnormal physiologic response to trauma. J Crit Care 2011;26:295-302.
19. Sperry JL, Frankel HL, Nathens AB, et al. Characterization of persistent hyperglycemia: What does it mean postinjury? J Trauma 2009;66:1076-1082.
20. Collier B, Diaz J Jr, Forbes R, et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN J Parenter Enteral Nutr 2005;29:353-358.
21. Czupryniak L, Strzelczyk J, Pawlowski M, et al. Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients. Obes Surg 2004;14:1393-1397.
22. Vriesendorp TM, Morelis QJ, DeVries JH, et al. Early postoperative glucose levels are an independent risk factor for infection after peripheral vascular surgery: A retrospective study. Eur J Vasc Endovasc Surg 2004;28:520-525.
23. Richards JE, Kauffmann RM, Zuckerman SL, et al. The relationship of stress-induced hyperglycemia and surgicalsite infection in orthopedic surgery. J Bone Joint Surg (submitted. 2011).
24. Bochicchio GV, Bochicchio KM, Joshi M, et al. Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients. Ann Surg 2010;252:597-602.
25. Mowery NT, Carnevale RJ, Gunter OL, et al. Insulin resistance heralds positive cultures after severe injury. Surg Infect 2009;10L593-509.
26. Martin RS, Smith JS, Hoth JJ, et al. Increased insulin requirements are associated with pneumonia after severe injury. J Trauma 2007;63:358-364.
27. Maloney N, Britt RC, Rushing GD, et al. Insulin requirements in the intensive care unit in response to infection. Am Surg 2008;74:845-848.
28. Carlson GL. Hunterian Lecture: Insulin resistance in human sepsis: Implications for the nutritional and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl 2004;86:75-81.
29. Collier B, Dossett LA, May AK, et al. Glucose control and the inflammatory response. Nutr Clin Pract 2008;23:3-15.
30. Shamoon H, Hendler R, Sherwin RS. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab 1981;52:1235-1241.
31. Jeevanandam M, Young DH, Schiller WR. Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma 1990;30:582-589.
32. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest 2008;118:2992-3002.
33. Draznin B. Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: The two sides of a coin. Diabetes 2006;55:2392-2397.
34. Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery. Br J Surg 1994;81:59-63.
35. Long CL, Schaffel N, Geiger JW, et al. Metabolic response to injury and illness: Estimation of energy and protein needs from indirect calorimetry and nitrogen balance. JPEN J Parenter Enteral Nutr 1979;3:452-456.
36. Mowery NT, Dortch MJ, Dossett LA, et al. Review of a large clinical series: Insulin resistance despite tight glucose control is associated with mortality in critically ill surgical patients. J Intensive Care Med 2009;24:242-251.
37. Mowery NT, Gunter OL, Guillamondegui O, et al. Stress insulin resistance is a marker for mortality in traumatic brain injury. J Trauma 2009;66:145-151.
38. Mowery NT, May AK, Collier BC, et al. Glucose metabolism, not obesity, predicts mortality in critically ill surgical patients. Am Surg 2010;76:1377-1383.
39. Faria MS, Aguilar-Nascimento JE, Pimenta OS, et al. Preoperative fasting of 2 hours minimizes insulin resistance and organic response to trauma after video-cholecystectomy: A randomized, controlled, clinical trial. World J Surg 2009;33:1158-1164.
40. Biolo G, DeCicco M, Lorenzon S, et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit CareMed 2008;36:1768-1775.
41. Langouche L, Vander PS, Wouters PJ, et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 2007;92:3890-3897.
42. Thorell A, Rooyackers O, Myrenfors P, et al. Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. J Clin Endocrinol Metab 2004;89:5382-5386.
43. Bakalar B, Duska F, Pachl J, et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006;34:381-386.
44. Dechelotte P, Hasselmann M, Cynober L, et al. l-Alanyl-lglutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006;34:598-604.
45. Borel MJ, Williams PE, Jabbour K, et al. Parenteral glutamine infusion alters insulin-mediated glucose metabolism. JPEN J Parenter Enteral Nutr 1998;22:280-285.
46. Prada PO, Hirabara SM, de Souza CT, et al. l-Glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity. Diabetologia 2007;50:1949-1959.
47. Venkatesh B, Hickman I, Nisbet J, et al. Changes in serum adiponectin concentrations in critical illness: A preliminary investigation. Crit Care 2009;13:R105.
48. Owecki M. Fat tissue and adiponectin: New players in critical care? Crit Care 2009;13:174.
49. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: Lessons from translational research. Am J Clin Nutr 2010;91:258S-261S.
50. Wang C, Mao X, Wang L, et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem 2007;282:7991-7996.
51. Oya-Ito T, Naitou H, Masuda S, et al. Functional analyses of neutrophil-like differentiated cell lines under a hyperglycemic condition. Mol Nutr Food Res 2008;52:360-369.
52. Stegenga ME, van der Crabben SN, Dessing MC, et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157-164.
53. Stegenga ME, van der Crabben SN, Blumer RM, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008;112:82-89
54. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003;144:5329-5338.
55. Fernandez-Real JM, Broch M, Richart C, et al. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1780-1784.
56. Kwoun MO, Ling PR, Lydon E, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997;21:91-95.
57. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990;30:830-832.
58. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998;101:1905-1915.
59. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002;106:2067-2072.
60. Krogh-Madsen R, Moller K, Dela F, et al. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004;286:E766-E772.
61. Kim SH, Park KW, Kim YS, et al. Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism. Endothelium 2003;10:65-70.
62. Ceriello A, Quagliaro L, Piconi L, et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004;53:701-710.
63. Sampson MJ, Davies IR, Brown JC, et al. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 2002;22:1187-1193.
64. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989;38:1031-1035.
65. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: Impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006;55:1096-1105.
66. Turina M, Miller FN, Tucker CF, et al. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg 2006;243:845-851.
67. Deng HP, Chai JK. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis. Int Immunopharmacol 2009;9:1251-1259.
68. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-361.
69. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314:1512-1515.
70. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
71. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
72. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. Can Med Assoc J 2009;180:821-827.
73. Jeschke MG, Kulp GA, Kraft R, et al. Intensive insulin therapy in severely burned pediatric patients: A prospective randomized trial. Am J Respir Crit Care Med 2010;182:351-359.
74. De La Rosa GC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: A randomised clinical trial. Crit Care 2008;12:R120.
75. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: A randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156-160.
76. Emam IA, Allan A, Eskander K, et al. Our experience of controlling diabetes in the peri-operative period of patients who underwent cardiac surgery. Diabetes Res Clin Pract 2010;88:242-246.
77. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 2007;146:233-243.
78. Gandhi GY, Murad MH, Flynn DN, et al. Effect of perioperative insulin infusion on surgical morbidity and mortality: Systematic review and meta-analysis of randomized trials. Mayo Clin Proc 2008;83:418-430.
79. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(Suppl 2):46-52.
80. Kao LS, Meeks D, Moyer VA, et al. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev 2009;CD006806.
81. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-1502.
82. Li JY, Sun S, Wu SJ. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Tex Heart Inst J 2006;33:445-451.
83. Quinn DW, Pagano D, Bonser RS, et al. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial. J Thorac Cardiovasc Surg 2006;131:34-42.
84. Subramaniam B, Panzica PJ, Novack V, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: A prospective, randomized trial. Anesthesiology 2009;110:970-977.
85. Nygren JO, Thorell A, Soop M, et al. Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. Am J Physiol 1998;275:E140-E148.
86. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality. Crit Care Med 2009;37:2536-2544.
87. Hermanides J, Bosman RJ, Vriesendorp TM, et al. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010;38:1430-1434.
88. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007;35:2262-2267.
89. Mowery NT, Guillamondegui OD, Gunter OL, et al. Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma 2010;68:342-347.
90. Vriesendorp TM, DeVries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006;34:2714-2718.
91. Kauffmann RM, Hayes RM, Jenkins JM, et al. Provision of balanced nutrition protects against hypoglycemcia in the critically ill surgical patient. JPEN J Parenter Enteral Nutr (in press).
92. Kauffmann RM, Hayes RM, Buske BD, et al. Increasing blood glucose variability heralds hypoglycemia in the surgically critically ill. J Surg Res 2011, Mar. 31. Epub ahead of print.
93. Dossett LA, Collier B, Donahue R, et al. Intensive insulin therapy in practice: Can we do it? JPEN J Parenter Enteral Nutr 2009;33:14-20.
94. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: A prospective randomized trial. Diabetes Care 2010;33:467-472.
95. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006;34:96-101.
96. Cao H, Boyang L, Gross B, et al. Delayed intravenous insulin therapy initiation is associated with mortality in the ICU. Crit Care Med 2010;38(12 suppl):246.
97. Corneille MG, Villa C, Wolf S, et al. Time and degree of glycemic derangement are associated with increased mortality in trauma patients in the setting of tight glycemic control. Am J Surg 2010;200:832-837.
98. Kreutziger J, Schlaepfer J, Wenzel V, et al. The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. J Trauma 2009;67:704-708.
99. Kreutziger J, Wenzel V, Kurz A, et al. Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients. Intensive Care Med 2009;35:1234-1239.
100. Al Dorzi HM, Tamim HM, Arabi YM. Glycaemic fluctuation predicts mortality in critically ill patients. Anaesth Intensive Care 2010;38:695-702.
101. Ali NA, O'Brien JM Jr, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008;36:2316-2321.
102. Dossett LA, Cao H, Mowery NT, et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008;74:679-685.
103. Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010;38:838-842.
104. Kaneki M, Sakai M, Shimizu N, et al. Is normalized mean blood glucose level good enough for the intensive care unit? Glycemic variability as a new independent predictor of mortality. Crit Care Med 2008;36:3104-3106.
105. Krinsley JS. Glycemic variability: A strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-3013.
106. Mohr AM, Lavery RF, Sifri ZC, et al. Gender differences in glucose variability after severe trauma. Am Surg 2010;76:896-902.
107. Pidcoke HF, Wanek SM, Rohleder LS, et al. Glucose variability is associated with high mortality after severe burn. J Trauma 2009;67:990-995.
108. Bagshaw SM, Bellomo R, Jacka MJ, et al. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009;13:R91.
109. Freire AX, Murillo LC. How "sweet" complexity is and how "bitter" variability can be: The new aspect of intensive care unit hyperglycemia. Crit Care Med 2010;38:996-997.
110. Krinsley JS. Glycemic variability and mortality in critically ill patients: The impact of diabetes. J Diabetes Sci Technol 2009;3:1292-1301.
111. Ouattara A, Grimaldi A, Riou B. Blood glucose variability: A new paradigm in critical care? Anesthesiology 2006;105:233-234.
112. Zhang XL, Lu JM, Shan GL, et al. Association between glucose variability and adverse in-hospital outcomes for Chinese patients with acute coronary syndrome. Saudi Med J 2010;31:1146-1151.
113. Eachempati SR, Hudo LJ, Shov J, Barie PS. Implementation of tight glucose control for critically ill surgical patients. A process improvement analysis. Surg Infect 2009;10:523-531.
114. Chase JG, Le Compte AJ, Suhaimi F, et al. Tight glycemic control in critical care: The leading role of insulin sensitivity and patient variability: A review and model-based analysis. Comput Methods Programs Biomed 2011;102:156-171.
115. Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: A systematic review. Ann Intern Med 2011;154:268-282.
116. Lipshutz AK, Gropper MA. Perioperative glycemic control: An evidence-based review. Anesthesiology 2009;110:408-421.
117. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: A systematic review and metaanalysis. Chest 2010;137:544-551.
118. Henderson WR, Finfer S. Differences in outcome between the NICE-SUGAR and Leuven trials: Possible methodological explanations. Crit Care Resusc 2009;11:175-177.
119. Myburgh JA, Chittock DR. Differences in outcome between the NICE-SUGAR and Leuven trials: Biological mechanisms of intensive glucose control in critically ill patients. Crit Care Resusc 2009;11:178-179.
120. Preiser JC. NICE-SUGAR: The end of a sweet dream? Crit Care 2009;13:143.
121. Van Den Berghe G, Schetz M, Vlasselaers D, et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-3170.
122. Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;154:260-267.
123. Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008;248:585-591.
124. King JT Jr, Goulet JL, Perkal MF, et al. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg 2011;253:158-165.
125. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34:256-261.